Clinical trial webinar

If you're interested in clinical trial design trends, be sure to sign up for our online webinar tomorrow at 1 p.m. EST. We have around 550 people registered for the webinar, which features the thoughts of Tufts' Kenneth Katin, PricewaterhouseCoopers' Neil Patel and Ray Woosley from the Critical Path Institute. I'd like to thank our sponsor, Insightful, for making it happen. - John Carroll

Suggested Articles

Janssen’s BCMA-targeting CAR-T therapy eliminated tumors in 69% of patients with advanced multiple myeloma in a small phase 1 study.

In a study, BMS' CAR-T therapy banished tumors in more than half and shrank tumors in nearly three-quarters of relapsed blood cancer patients.

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.